{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:57:55Z","timestamp":1790287075377,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1C1B2008643"],"award-info":[{"award-number":["2017R1C1B2008643"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A3B03030324"],"award-info":[{"award-number":["2017R1D1A3B03030324"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C1005395"],"award-info":[{"award-number":["2021R1A2C1005395"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.113032","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T18:58:16Z","timestamp":1650999496000},"page":"113032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma"],"prefix":"10.1016","volume":"150","author":[{"given":"Kausik","family":"Bishayee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uddin Md.","family":"Nazim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaebong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Oh","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113032_bib1","first-page":"179","article-title":"Neuroblastoma: a clinical challenge and biologic puzzle","volume":"45","author":"Matthay","year":"1995","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2022.113032_bib2","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.celrep.2017.12.002","article-title":"Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis","volume":"21","author":"Yue","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2022.113032_bib3","doi-asserted-by":"crossref","first-page":"7954854","DOI":"10.1155\/2019\/7954854","article-title":"Nuclear imaging of glucose metabolism: beyond (18)F-FDG","volume":"2019","author":"Feng","year":"2019","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.biopha.2022.113032_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.113032_bib5","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2022.113032_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101589","article-title":"FoxM1-dependent and fatty acid oxidation-mediated ROS modulation is a cell-intrinsic drug resistance mechanism in cancer stem-like cells","volume":"36","author":"Choi","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.113032_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fonc.2020.00791","article-title":"Beyond the warburg effect: N-Myc contributes to metabolic reprogramming in cancer cells","volume":"10","author":"Yoshida","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113032_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the Warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113032_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-019-0348-0","article-title":"Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect","volume":"17","author":"Luo","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2022.113032_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.113032_bib11","article-title":"Targeting MYCN in pediatric and adult cancers","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113032_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.isci.2019.10.020","article-title":"MYCN-enhanced oxidative and glycolytic metabolism reveals vulnerabilities for targeting neuroblastoma","volume":"21","author":"Oliynyk","year":"2019","journal-title":"IScience"},{"key":"10.1016\/j.biopha.2022.113032_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.33594\/000000134","article-title":"Targeting the difficult-to-drug CD71 and MYCN with gambogic acid and vorinostat in a class of neuroblastomas","volume":"53","author":"Bishayee","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2022.113032_bib14","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2022.113032_bib15","first-page":"157","article-title":"Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors","volume":"39","author":"Di Cosimo","year":"2003"},{"key":"10.1016\/j.biopha.2022.113032_bib16","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/2159-8290.CD-17-0177","article-title":"mTOR and HDAC inhibitors converge on the TXNIP\/thioredoxin pathway to cause catastrophic oxidative stress and regression of RAS-driven tumors","volume":"7","author":"Malone","year":"2017","journal-title":"Cancer Disco"},{"key":"10.1016\/j.biopha.2022.113032_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2022.113032_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/19768354.2018.1517824","article-title":"Modulatory effect of linoleic and oleic acid on cell proliferation and lipid metabolism gene expressions in primary bovine satellite cells","volume":"22","author":"Belal","year":"2018","journal-title":"Anim. Cells Syst."},{"key":"10.1016\/j.biopha.2022.113032_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2144\/04376RV01","article-title":"Chromatin immunoprecipitation assay","volume":"37","author":"Das","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.biopha.2022.113032_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1759-7714.12148","article-title":"Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy","volume":"6","author":"Li","year":"2015","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.biopha.2022.113032_bib21","article-title":"MYCN function in neuroblastoma development","volume":"10","author":"Otte","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.113032_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.stem.2016.08.008","article-title":"Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell state","volume":"19","author":"Gu","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biopha.2022.113032_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gdata.2015.11.012","article-title":"Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines","volume":"6","author":"Dassi","year":"2015","journal-title":"Genom. Data"},{"key":"10.1016\/j.biopha.2022.113032_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-020-01957-w","article-title":"Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells","volume":"21","author":"Zhang","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2022.113032_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","article-title":"Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma","volume":"50","author":"Zeid","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2022.113032_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008154","article-title":"Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation","volume":"4","author":"Murphy","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113032_bib27","first-page":"6999","article-title":"Three-dimensional cell culture: a powerful tool in tumor research and drug discovery","volume":"14","author":"Lv","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.113032_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113032_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2022.113032_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113032_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068859","article-title":"Cell survival signalling through PPAR\u03b4 and arachidonic acid metabolites in neuroblastoma","volume":"8","author":"Bell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113032_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.032","article-title":"Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells","volume":"1132","author":"Wang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2022.113032_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.31069","article-title":"Reactive oxygen species (ROS) are a key determinant of cancer\u2019s metabolic phenotype","volume":"142","author":"Rodic","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113032_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000488433","article-title":"Protodioscin induces apoptosis through ROS-mediated endoplasmic reticulum stress via the JNK\/p38 activation pathways in human cervical cancer cells","volume":"46","author":"Lin","year":"2018","journal-title":"Cell Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113032_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2018.06.123","article-title":"ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine","volume":"106","author":"Seervi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113032_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183680","article-title":"CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy","volume":"12","author":"Lei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113032_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.369","article-title":"PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR)","volume":"8","author":"Kranz","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113032_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88815","article-title":"GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance","volume":"2","author":"Kuang","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2022.113032_bib39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","article-title":"mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc","volume":"18","author":"Masui","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2022.113032_bib40","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.molonc.2015.04.005","article-title":"Thymosin-\u03b24 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma","volume":"9","author":"Cheung","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2022.113032_bib41","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1016\/j.ejca.2012.02.067","article-title":"Enhancing the anticancer effect of the histone deacetylase inhibitor by activating transglutaminase","volume":"48","author":"Ling","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2022.113032_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113032_bib43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113032_bib44","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","article-title":"mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells","volume":"29","author":"Pusapati","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2022.113032_bib45","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2022.113032_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100318","article-title":"Autocrine motility factor and its receptor expression in musculoskeletal tumors","volume":"24","author":"Nakajima","year":"2020","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.biopha.2022.113032_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","article-title":"mTOR signalling and cellular metabolism are mutual determinants in cancer","volume":"18","author":"Mossmann","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.113032_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121584","article-title":"Targeting mTOR and metabolism in cancer: lessons and innovations","volume":"8","author":"Magaway","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113032_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41392-020-00371-9","article-title":"Small is beautiful-a glycolytic metabolite signals mTORC1 activation in cancer cell metabolism","volume":"5","author":"Otto","year":"2020","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:35:55Z","timestamp":1780486555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":49,"alternative-id":["S0753332222004218"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113032","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113032"}}